Literature DB >> 2766888

Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms.

K A Alanen1, H Joensuu, P J Klemi.   

Abstract

Serial flow cytometric nuclear DNA content analyses were performed from normal human spleen, thyroid, liver, and pancreas removed from ten patients at autopsy and stored for up to 8 d without any preservative to study the effect of autolysis on DNA histograms. Fine needle aspiration biopsy (FNAB) samples were taken in diluted ethanol and tissue biopsies from the same area in formalin for embedding into paraffin at the time of autopsy and serially thereafter. Histograms obtained from samples taken within 10 h after death had a symmetrical G1 peak with a small coefficient of variance (CV) except histograms produced from paraffin-embedded pancreatic tissue, but bimodal distributions similar to those seen in aneuploid tumors were obtained from many samples stored longer than for 20 h. The DNA indices of the bimodal histograms were usually less than 1.3. The false peaks were more prominent in FNAB samples than in paraffin-embedded samples. The time of appearance of the false aneuploid peaks varied individually, and they were usually first seen in samples taken from the pancreas, followed by the liver, the thyroid and the spleen. Because neoplasms may become necrotic in vivo and fixation of fresh surgical samples may be slow and incomplete, increased DNA staining caused by autolysis may be a source of false aneuploid peaks in DNA content analysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766888     DOI: 10.1002/cyto.990100409

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  11 in total

1.  Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.

Authors:  N L Carlsen; K Ornvold; I J Christensen; H Laursen; J K Larsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

3.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.

Authors:  P S Rabinovitch; G Longton; P L Blount; D S Levine; B J Reid
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

4.  Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.

Authors:  S B Ewers; R Attewell; B Baldetorp; A Borg; E Långström; D Killander
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

5.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Authors:  B J Reid; D S Levine; G Longton; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

6.  Diagnostic value of DNA image cytometry in ulcerative colitis.

Authors:  R Keller; E C Foerster; A Köhler; B Floer; G Winde; H J Terpe; W Domschke
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

7.  DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinoma.

Authors:  J G Müller; S Demel; M P Wirth; A Manseck; H G Frohmüller; H A Müller
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Flow and image cytometric study of pancreatic neuroendocrine tumours: frequent DNA aneuploidy and an association with the clinical outcome.

Authors:  K A Alanen; U G Falkmer; P J Klemi; H Joensuu; S Falkmer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Aneuploidy in salivary gland adenomas.

Authors:  T Atula; R Grénman; P Laippala; P J Klemi
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.